Connexions Novartis AG

Actions

NOVN

CH0012005267

Produits pharmaceutiques

Temps réel estimé Cboe Europe 12:13:28 19/05/2026 Varia. 5j. Varia. 1 janv.
118,20 CHF +0,85% Graphique intraday de Novartis AG +1,98% +7,85%

46

Sociétés cotées

50

Entreprise privées

481

Insiders

Graphique Relationnel des Sociétés Cotées liées: Novartis AG

Relations Actives

Relations Passées

Sociétés Cotées liées: Novartis AG

Relations Actives

Relations Passées

Graphique Relationnel des Sociétés Privées liées: Novartis AG

Relations Actives

Relations Passées

Entreprise Privées liées: Novartis AG

Serica Technologies, Inc.

Pharmaceuticals: Major

abrdn Healthcare Investors

Investment Trusts/Mutual Funds

abrdn Life Sciences Investors

Investment Trusts/Mutual Funds

abrdn Healthcare Opportunities Fund

Investment Trusts/Mutual Funds

abrdn World Healthcare Fund

Investment Trusts/Mutual Funds

STADA Arzneimittel AG

Pharmaceuticals: Generic

Novo Holdings A/S (Denmark)

Investment Managers

Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

The General Hospital Corp.

Hospital/Nursing Management

Atlas Venture Advisors, Inc.

Investment Managers

Northwestern University

Other Consumer Services

University of St. Gallen

Other Consumer Services

American Bar Association

Miscellaneous Commercial Services

Novartis Pharmaceuticals Corp.

Pharmaceuticals: Major

Speedel Pharma AG

Pharmaceuticals: Major

National Academy of Sciences

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

National Academy of Medicine (United States)

Miscellaneous Commercial Services

The District of Columbia Bar

Miscellaneous Commercial Services

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Massachusetts Biotechnology Council

Miscellaneous Commercial Services

Novartis Institutes for Biomedical Research, Inc.

Miscellaneous Commercial Services

Harvard Medical School

Other Consumer Services

Waters Technologies Corp.

Medical Specialties

E. Merck KG

Pharmaceuticals: Major

SIX Swiss Exchange AG

Investment Banks/Brokers

Novartis Pharma KK

Pharmaceuticals: Major

The Consumer Goods Forum

Miscellaneous Commercial Services

Association of the European Self-Medication Industry

Affidea BV

Medical/Nursing Services

Galderma Holding SA

Pharmaceuticals: Major

Vasomune Therapeutics, Inc.

Pharmaceuticals: Other

Fore Biotherapeutics, Inc.

Pharmaceuticals: Major

Tango Therapeutics Sub, Inc.

Biotechnology

Aberdeen Investments LLC

Financial Conglomerates

CIBA Vision GmbH (Germany)

Electronic Components

ImmunOs Therapeutics AG

Biotechnology

Ring Therapeutics, Inc.

Pharmaceuticals: Major

Valo Health LLC

Packaged Software

Abata Therapeutics, Inc.

Biotechnology

Relations Actives

Relations Passées

Statistiques des Connexions

Actives

Inactives

Sociétés cotées

Entreprise privées

Activités des Sociétés liées

Pharmaceuticals: Major20
Biotechnology16
Miscellaneous Commercial Services14
Medical Specialties9
Other Consumer Services4
Investment Trusts/Mutual Funds4
Industrial Machinery3
Food: Specialty/Candy2
Other Transportation2
Investment Managers2

Pays des Sociétés liées

Etats-Unis42
Suisse28
Allemagne6
Pays-Bas5
Belgique4
Royaume-Uni3
Canada3
France2
Japon1
Danemark1
Logo Novartis AG
Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA par domaine thérapeutique se répartit comme suit : - oncologie (30,9%) ; - immunologie (18,9%) ; - maladies cardio-vasculaires, rénales et métaboliques (16,4%) ; - neuroscience (11%) ; Le solde du CA (22,8%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques. A fin 2025, Novartis AG dispose de plus de 31 sites de production dans le monde. La répartition géographique du CA est la suivante : Suisse (2,6%), Europe (28,1%), Etats-Unis (42,8%), Asie-Afrique-Australasie (19,8%), Canada et Amérique latine (6,7%).
Employés
75 267